The aging population with schizophrenia may still experience symptoms as they age in addition to the increased risk for psychosis they have due to age-related deterioration of cortical areas and neurochemical changes, comorbid physical illnesses, social isolation, sensory deficits, and polypharmacy.  This webinar will evaluate current literature to review the current utilization of long-acting injectable antipsychotic medications in this population.  Review and management of potential adverse effects in the aging population who utilize long-acting injectable antipsychotic medications will be presented.  Clinical pearls on the development of an administration and treatment plan for long-acting injectable antipsychotic medications use in an aging population will be reviewed for incorporation in practice.

Format

Live interactive webinar

Learning Objectives

• Evaluate the utilization of long-acting injectable antipsychotic medications in an aging population.
• Manage the adverse effects of long-acting injectable antipsychotic medications in an aging population.
• Develop an administration and treatment plan for the use of long-acting injectable antipsychotic medications in an aging population.

Target Audience

Nurse/Nurse Practitioner, Psychiatrist, Pharmacist, Physician (non-psychiatrist), Physician Assistant

Instructional Level

Introductory, Intermediate

Estimate Time to Complete

Estimated Duration: 1.0 hour
Program Start Date: June 8, 2023
Program End Date: June 8, 2023

Attendees will have an opportunity to participate in Q&A.

How to Earn Credit

Participants who wish to earn AMA PRA Category 1 Credit™, nursing continuing professional development contact hours (NCPD, formerly CNE), or a certificate of participation may do so by viewing the live presentation and completing the evaluation. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians), NCPD certificate (nurses), or certificate of participation (other disciplines) showing the event date and hours earned.

Continuing Education Credit

In support of improving patient care, the American Psychiatric Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physicians

The APA designates this live event for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nurses/Nurse Practitioners

The American Psychiatric Association (APA) designates this activity for 1.0 Nursing contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.

Faculty and Planner Disclosures

The American Psychiatric Association adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME activity — including faculty, planners, reviewers or others — are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Instructors

• Megan Ehret, PharmD, MS, BCPP is an Associate Professor at University of Maryland, School of Pharmacy. Dr. Ehret completed her BS and PharmD degrees from the University of Toledo. Additionally, Dr. Ehret received her Master in Clinical and Translational Research from the University of Connecticut Health Center. Dr. Ehret is also a Board-Certified Psychiatric Pharmacist. Most recently Dr. Ehret has practiced at Fort Belvoir Community Hospital as their Behavioral Health Clinical Pharmacy Specialist. She has experience in treating the spectrum of mental illnesses and substance use disorders. Additionally, she is President-Elect for the College of Psychiatric and Neurologic Pharmacists (CPNP) and serves as the Senior Editor on the Psychiatric Pharmacotherapy Review Course. Dr. Ehret has no relevant financial relationships to disclose.

Planners

• Teri Brister, PhD, LPC, National Alliance on Mental Illness. Dr. Brister has no relevant financial relationships to disclose.
• John Torous, MD, Beth Israel Deaconess Medical Center. Dr. Torous has no relevant financial relationships to disclose.
• Kathryn Hanley, RN, LPA, PMHNP-BC, University of Texas at Austin. Ms. Hanley has no relevant financial relationships to disclose. 

Accessibility for Participants with Disabilities

The American Psychiatric Association is committed to ensuring accessibility of its website to people with disabilities. Please contact the American Psychiatric Association at 202-559-3900, if you require assistance seven (7) business days prior to the start of a live webinar.

Technical Requirements

This internet-based CME activity is best experienced using any of the following:

• The latest and 2nd latest public versions of Google Chrome, Mozilla Firefox, or Safari
• Internet Explorer 11+

This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Acrobat Reader, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration:

• Browser: Google Chrome (latest and 2nd latest version), Safari (latest and 2nd latest version), Internet Explorer 11.0+, Firefox (latest and 2nd latest version), or Microsoft Edge (latest and 2nd latest version)
• Operating System: Windows versions 8.1+, Mac OS X 10.5 (Leopard) +, Android (latest and 2nd latest version), or iOS/iPad OS (latest and 2nd latest version)
• Internet Connection: 1 Mbps or higher

Minimum Requirements:

• Windows PC: Windows 8.1 or higher; 1 GB (for 32-bit)/2 GB (for 64-bit) or higher RAM; Microsoft DirectX 9 graphics device with WDDM driver; audio playback with speakers for programs with video content
• Macintosh: Mac OS X 10.5 or higher with latest updates installed; Intel, PowerPC G5, or PowerPC G4 (867MHz or faster) processor; 512 MB or higher RAM; audio playback with speakers for programs with video content

For assistance: Contact educme@psych.org for questions about this activity | Contact SMIadviserhelp@psych.org for technical assistance